Stabilization of neuropathy scores seen after gene editing therapy for rare nerve disease

“Sometimes with my roommates home, I'll, like, turn the water on because I'm like, I don't want them to think I'm, like, disgusting.”View Entire Post ›

From Béis to Baggu, here are some great travel and toiletry bag options for your next trip.View Entire Post ›

It's not too late to turn it all around.View Entire Post ›

According to Instagram, Bieber counts the multitasking formula among her empties.View Entire Post ›

“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.”View Entire Post ›

The Embryolisse Lait-Crème Concentré is a multi-tasking hidden gem of a facial cream.View Entire Post ›

After the model opened up about her experience being diagnosed with type 1 diabetes, we asked experts about the autoimmune condition, the differences between type 1 and type 2 diabetes, and how this diagnosis can change your life.View Entire Post ›

An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›

There's a long-held belief in diabetes prevention that weight loss is the main way to lower disease risk. Our new study challenges this.

It's late at night, and you have been stewing all day about something your partner did to annoy you. The time to resolve it is now because, as everyone knows, you should never go to bed angry, right?

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from spreading. Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate to distant organs. The preclinical study also found drugs that block EZH2 could restore order to dividing cells and thwart the spread of TNBC cells.

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease progression and survival in patients with fibrotic interstitial lung disease. The findings, recently published in the American Journal of Respiratory and Critical Care Medicine, suggest that computer-based image analysis may provide an earlier, more objective way to identify patients at highest risk for worsening disease.

The symptoms come on quickly—acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly severe for high-risk individuals, including newborns and older adults.

Depression is a serious disorder that disrupts daily life through lethargy, sleep disturbance, and social withdrawal, and also increases the risk of suicide. The number of depression patients has steadily increased over the years, affecting more than 280 million people worldwide as of 2025. Now, researchers have uncovered a new pathological mechanism that could provide clues for the diagnosis and treatment of depression.

A key switch for cellular energy balance has been discovered in cells, and it could potentially become the target of new therapies for diseases ranging from Parkinson's to rare disorders caused by defects in mitochondria.

New research investigating health outcomes in NCAA athletes during their first year after leaving college sports found that some health measures were worse than expected, but others actually improved.

Persistent racial differences in flu vaccination uptake are seen across ages and flu seasons, according to a study published in the Oct. 3 issue of Vaccine.

Denied insurance claims are among the biggest challenges facing the U.S. health care system—driving up costs and leaving providers with billions in unpaid bills.